Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Chris Ogden
Affiliation
The Royal Marsden Hospital NHS Foundation Trust
ORCID
Career Start Year
1993
Papers
36
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35123819
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.
Eur Urol
2022
33504940
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study.
Prostate Cancer Prostatic Dis
2021
32253928
An Exploratory Study of Dose Escalation <i>vs</i> Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer.
J Endourol
2020
29662167
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
Nat Genet
2018
29960750
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
Eur Urol
2018
28945760
Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.
PLoS Genet
2017
26951947
Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.
Eur Urol
2016
25749786
Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.
Eur Radiol
2015
26018901
Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.
Nat Genet
2015
25730763
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.
Nat Genet
2015
23065704
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.
Hum Mol Genet
2013
23774040
A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.
Contemp Clin Trials
2013
23535732
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Nat Genet
2013
21743467
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
Nat Genet
2011
19040532
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
BJU Int
2009
27628454
Port site hernias following robot-assisted laparoscopic prostatectomy.
J Robot Surg
2009
19767753
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Nat Genet
2009
19767752
Multiple loci on 8q24 associated with prostate cancer susceptibility.
Nat Genet
2009
19513068
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series.
Br J Cancer
2009
19050691
Identification of new genetic risk factors for prostate cancer.
Asian J Androl
2009
18165275
Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.
J Mol Diagn
2008
18264097
Multiple newly identified loci associated with prostate cancer susceptibility.
Nat Genet
2008
17125476
Visually directed high-intensity focused ultrasound for organ-confined prostate cancer: A proposed standard for the conduct of therapy.
BJU Int
2006
17520650
Robotic prostatectomy: the first UK experience.
Int J Med Robot
2006
15610124
Urine dendritic cells: a noninvasive probe for immune activity in bladder cancer?
BJU Int
2004
11680707
Exclusive amplification of cDNA template (EXACT) RT-PCR to avoid amplifying contaminating genomic pseudogenes.
Biotechniques
2001
11371938
Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.
J Urol
2001
10848690
Morbidity and the impact on daily activities associated with catheter drainage after acute urinary retention.
BJU Int
2000
12497162
Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer.
Prostate Cancer Prostatic Dis
2000
10368252
The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with de-differentiation.
BJU Int
1999
9806178
Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.
Br J Urol
1998
9158510
Multiple frequent recurrences in superficial transitional cell carcinoma of the bladder: is survival compromised by a conservative management strategy?
Br J Urol
1997
8800890
A 12-month study of the placebo effect in transurethral microwave thermotherapy.
Br J Urol
1996
7536261
The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study.
J Urol
1995
7678047
Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction.
Lancet
1993
7683985
Clinical response to transurethral microwave thermotherapy is thermal dose dependent.
Eur Urol
1993
1 - 36 of 36
Column Actions
Search
Recommended Authors
Jonathan L Wright
University of Washington Medical Center
Career Start Year
2005
Number of shared co-authors
8
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year
2001
Number of shared co-authors
17
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year
1997
Number of shared co-authors
25
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year
1995
Number of shared co-authors
2
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year
1994
Number of shared co-authors
3
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year
1994
Number of shared co-authors
8
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year
1994
Number of shared co-authors
6
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year
1993
Number of shared co-authors
5
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year
1992
Number of shared co-authors
4
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year
1991
Number of shared co-authors
4
Neil E Fleshner
University of Toronto
Career Start Year
1989
Number of shared co-authors
43
Mark Frydenberg
Monash University
Career Start Year
1988
Number of shared co-authors
11
Philip Cornford
Liverpool University Hospitals
Career Start Year
1988
Number of shared co-authors
3
Christopher P Evans
University of California Davis
Career Start Year
1988
Number of shared co-authors
13
Damien Bolton
University of Melbourne
Career Start Year
1988
Number of shared co-authors
7
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year
1987
Number of shared co-authors
16
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year
1987
Number of shared co-authors
2
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year
1984
Number of shared co-authors
7
Eric A Klein
Cleveland Clinic
Career Start Year
1984
Number of shared co-authors
41
Joseph L Chin
University of Western Ontario
Career Start Year
1982
Number of shared co-authors
2
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year
1981
Number of shared co-authors
4
Lawrence D True
University of Washington School of Medicine
Career Start Year
1980
Number of shared co-authors
7
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Career Start Year
1977
Number of shared co-authors
12
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year
1975
Number of shared co-authors
6
Keong Tatt Foo
Rutgers Cancer Institute of New Jersey
Career Start Year
1975
Number of shared co-authors
3
Anthony J Costello
Royal Melbourne Hospital
Career Start Year
1974
Number of shared co-authors
13
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year
1974
Number of shared co-authors
17
John Trachtenberg
University of Toronto, University Health Network
Career Start Year
1971
Number of shared co-authors
4
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year
1971
Number of shared co-authors
3
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year
1956
Number of shared co-authors
36
row(s) 1 - 30 of 30
Collaborators
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers
13
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers
13
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers
13
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers
13
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers
11
Christopher J Woodhouse
Royal Marsden NHS Foundation Trust
Co-authored papers
11
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Co-authored papers
11
Douglas F Easton
University of Cambridge
Co-authored papers
10
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers
10
Freddie C Hamdy
University of Oxford
Co-authored papers
9
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers
9
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers
8
Sandra Edwards
The Institute of Cancer Research
Co-authored papers
8
Graham G Giles
Co-authored papers
7
Jonathan Morrison
Co-authored papers
6
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers
6
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Co-authored papers
5
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers
5
Cathy Corbishley
The Institute of Cancer Research
Co-authored papers
5
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Co-authored papers
5
Erik Mayer
Imperial Clinical Analytics
Co-authored papers
5
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers
5
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers
4
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
David Jones
Wellcome Sanger Institute
Co-authored papers
4
Hayley C Whitaker
University College London
Co-authored papers
4
Judith A Clements
Co-authored papers
4
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers
4
Hayley J Luxton
University College London
Co-authored papers
4
Barbara Kremeyer
University College London
Co-authored papers
4
1 - 30